Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Industrial Access was the star performer

Acrow
3:27pm
February 27, 2025
ACF’s 1H25 result was in line with our expectations and management’s guidance provided in November. The result was driven by strong growth in Industrial Access, partly offset by lower contributions from Formwork and Commercial Scaffold. Management has maintained FY25 revenue and EBITDA guidance in addition to providing underlying NPAT and underlying EPS targets. We make no changes to FY25F EBITDA but lift FY26F and FY27F EBITDA marginally (by 1-2%). Our target price rises slightly to $1.32 (from $1.30). In our view, ACF’s increasingly diversified business that includes screens, jumpform, industrial access and formwork in addition to ongoing new product development provides multiple growth levers in an operating environment that remains healthy. Trading on 8.6x FY26F PE and 5.7% yield, we believe the long-term investment proposition remains attractive and maintain our Add rating.

Cash machine

Qantas Airways
3:27pm
February 27, 2025
QAN reported an in line 1H25 result with Jetstar’s strong growth, better than expected FCF and a large fully franked dividend (first since COVID) the highlights. Whilst QAN’s operating environment remains favourable, we continue to see the stock fully valued at current levels. HOLD maintained.

A nice 2Q25 turn around

Clearview Wealth
3:27pm
February 27, 2025
Overall we saw this result as delivering well after a tough 1Q25. The key highlight being claims normalising in 2Q25, and all key FY26 targets being re-affirmed (with a lift to the gross premium target). We increase our CVW FY25F/FY26F EPS by 2%-16% on higher top-line growth and improved claims assumptions. Our PT increases to A$0.65. On face value, the claims spike CVW saw in 1Q25 looks like a blip rather than a trend. We see significant upside in CVW at current levels and maintain our ADD call.

Back on the throttle

Motorcycle Holdings
3:27pm
February 27, 2025
MTO continued its recent momentum through to the end of 1H25, delivering an improved result, with sales +12%; EBITDA +20%; and NPAT up 43%. The result was ~4% ahead of our sales and ~7% ahead of our NPAT expectations – a positive start to the year after a challenging FY24. Strong sales growth within Mojo (+21%) and New/Used MCs (+11%) drove the result, as sales growth accelerated towards the end of the CY24. The group remains cautiously optimistic for another positive 2H25 result, with some momentum carrying into January. We are encouraged by the ongoing recovery of the business and view MTO as well positioned for a turn in the cycle. We continue to view the valuation as undemanding on 8x FY25F PE and an 8% yield. Add.

1H25 and outlook disappoints

Helloworld
3:27pm
February 27, 2025
HLO’s 1H25 result materially missed our forecast and consensus expectations. EBITDA fell 20% on the pcp, despite the 1H25 having an additional month of the acquisitions. The highlight was the large interim dividend given HLO’s strong balance sheet. FY25 EBITDA guidance was also significantly below consensus estimates. Guidance implies a stronger 2H vs 1H and HLO highlighted its solid forward bookings. We have made large downgrades to our forecasts. Despite HLO’s undemanding trading multiples, we maintain a Hold rating until there is a clearer picture on its outlook and earnings growth resumes.

Margin improvement coming

Monash IVF
3:27pm
February 27, 2025
MVF’s 1H25 result was in line with guidance provided, with NPAT up 5.5% to $15.8m. Short term volatility in industry cycle volumes does not alter our view of the strong structural growth drivers that we think will underpin growth in the IVF industry. We expect MVF to continue to gain market share in Australia, leverage infrastructure and patient management system to drive higher margins and continue to expand in South East Asia, which we think will drive growth in earnings over the next few years. We have lowered our NPAT in line with guidance provided. We have decreased our target price to $1.45 (from $1.50) driven by earnings revisions. ADD retained.

1H inline- EU jettison? Only one piece of the puzzle

Ramsay Health Care
3:27pm
February 27, 2025
1H underlying operating profit was pre-released so unsurprisingly in line, driven by low single digit admissions growth and indexation gains. However, earnings were a mixed bag, with growth in Australia and UK acute hospitals, while Elysium and EU went backwards on going inflationary pressures. While it is a welcome sign “strategic options” are actively being pursued for the EU division, with possible divestment in the air, new management flagged a multi-year transformation is required in remaining business and it continues to run a ruler across all divisions, making it difficult at this early stage to assess if adjustments in operational strategy will have the desired impact. We adjust FY25-27 earnings, with our price target decreasing to A$37.10. Hold.

Things starting to come together

Coles Group
3:27pm
February 27, 2025
COL’s 1H25 result was above expectations with the performance of the core Supermarkets division the key standout. Key positives: COL delivered $157m of Simplify & Save to Invest (SSI) cost savings during the half, taking cumulative savings to ~$400m over the past 18 months; COL invested significantly into resources to take advantage of industrial action that impacted operations at Woolworths (WOW), which yielded an extra $20m in EBIT during the half. Key negatives: Liquor EBIT was below (-12%) our forecast, although the market saw some slight recovery in November and December; Cash realisation at 69% was low due to the timing of payments but should revert to ~100% for the full year. We lift FY25-27F underlying EBIT by between 3-4%. Our target price increases to $20.90 (from $17.95) on the back of updates to earnings estimates and a roll-forward of our model to FY26 forecasts. Hold rating maintained.

Turnaround in full swing

Intelligent Monitoring Group
3:27pm
February 27, 2025
The result was robust with EBITDA +23% YoY and NPATA +41%. Both Australia and NZ delivered organic revenue growth of +6% YoY and +4%, respectively. The company expects this growth to accelerate materially given recent contract wins in ADT Australia with large enterprise customers. Guidance has been re-affirmed for >$38m EBITDA excluding FY25 acquisitions, implying organic earnings growth of at least +24% HoH. We upgrade our EBITDA forecasts to align with new guidance (>$40m including acquisitions). We forecast FY25 and FY26 EPSA growth of +34% and +51%, respectively. IMB is now trading on 5x FY26 PE. This is too cheap given the growth outlook, cash generation potential ($23m tax credits and $7-8m annual interest savings from the re-fi) and balance sheet capacity (1.4x leverage).

Strap yourself for an exciting 2025

Imricor Medical Systems
3:27pm
February 27, 2025
IMR posted its FY24 result which was in line with our forecast on an underlying basis (albeit lower sales were offset by lower costs). IMR finished the period with US$15.7m in cash, a comfortable position to drive operations forward over the coming quarters. FY25 is setting up to be an exciting year with a number of key catalysts to drive investor interest: (first ventricular tachycardia procedure (European trial); Northstar mapping approval (Europe and US); and approval for atrial flutter (in the US). We have reviewed our forecasts revising down FY25/26 by ~10% and upgrading FY27 by 34% reflecting growing sales momentum as more sites come on board and procedures are performed. As a result our DCF valuation has increased to A$2.18 (was A$1.51). Speculative buy recommendation maintained.

News & Insights

The U.S. and China, through negotiations led by the Chinese Deputy Premier and U.S. Treasury Secretary Scott Bessent, agreed to a 90-day tariff reduction from over 125% to 30% and 10% respectively

US and Chinese actions had led to an unintended embargo of trade between the world’s two largest economies.

In recent days there has been discussion of the temporary “cease fire” in the tariff war between the US and China.

The situation was that both countries had levied tariffs on each other more than 125%. This had led to a mutual embargo of trade between the two world is two largest economies. Then as a result of negotiation between the Deputy Premier of China and US Treasury Secretary Scott Bessent both China and the US agreed to a 90 day pause in “hostilities” where both sides agreed to reduce the US tariff on the China to 30 percent and the Chinese tariff on the US to 10%.

Some suggested that this meant that “China had won” others suggested that the “US had won.” To us this really suggests that both parties were playing in a different game. The was a game in which both sides had won.

To understand why this is the case we must understand a little of the theory of this type of competition. Economists usually use discuss competition in terms of markets where millions of people are involved. In such a case we find a solution by finding the intersection of supply and demand which model the exchange between vast numbers of people.

But here we are ware talking of a competition where only two parties are involved.

When exceedingly small numbers like this are involved, we find the solution to the competition by what is called “Game Theory.”

In this game there are only two players. One is called China, and the other is called the US. Game theory teaches us that are there three different types of games. The first is a zero-sum game. In this game there two sides are competing over a fixed amount of product. Again, this is called " A zero sum game “. Either one party gets a bigger share of the total sum at stake and the other side gets less. This zero-sum game is how most of the Media views the competition between the US and China.

A second form is a decreasing sum game. An example of this is a war. Some of the total amount that is fought over is destroyed in the process. Usually both sides will wind up worse than when they started.

Then there is a third form. This form is called an ‘increasing sum game.’ This is where both sides cooperate so that the total sum in the game grows because of this cooperation. We think that what happened in the US and China negotiation was an increasing sum game.

As Scott Bessent said at the Saudi Investment Forum in Riyadh soon after the agreement was signed, “both sides came with a clear agenda with shared interests and great mutual respect.”

He said, “after the weekend, we now have a mechanism to avoid escalation like we had before. We both agreed to bring the tariff levels down by 115% which I think is very productive because where we were with 145% and 125% was an unintended embargo. That is not healthy for the two largest economies in the world.”

He went on, “when President Trump began the tariff program, we had a plan, we had a process. What we did not have with the Chinese was a mechanism. The Vice Premier and I now call this the ‘Geneva mechanism’”.

Both sides cooperated to make both sides better off. Bessent added “what we do not want, and both sides agreed, is a generalised decoupling between the two largest economies in the world. What we want is the US to decouple in strategic industries, medicine, semiconductors, other strategic areas. As to other countries; we have had very productive discussions with Japan, South Korea, Indonesia, Taiwan, Thailand. Europe may have collective action problems with the French wanting one thing and the Italians wanting a different thing. but I am confident that with Europe, we will arrive at a satisfactory conclusion.

We have a very good framework. I think we can proceed from here.”

What we think we can see here is that the United States and China have cooperated to both become better off. This is what we call an increasing sum game.

They will continue their negotiation using that approach. This will do much to allay the concerns that so many had about the effect of these new tariffs.

Read more
Treasury Secretary Scott Bessent’s adept negotiation of a US-China tariff deal and his method for assessing tariffs’ modest impact on inflation, using a 20.5% effective rate, position him as a formidable successor to Henry Morganthau’s legacy.

In the 1930s, the US Treasury Secretary Henry Morganthau was widely regarded as the finest Treasury Secretary since Alexander Hamilton. However, if the current Treasury Secretary Scott Bessent, continues to deliver results as he is doing now, he will provide formidable competition to Morganthau’s legacy.

The quality of Bessent’s work is exceptional, demonstrated by his ability to secure an agreement with China in just a few days in complex circumstances.

The concept of the "effective tariff rate" is a term that has gained traction recently. Although nominal tariff rates on individual goods in individual countries might be as high as 100% or 125%; the effective tariff rate, which reflects the actual tariffs the US imposes on imports from all countries, is thought to be only 20.5%. This figure comes from an online spreadsheet published by Fitch Ratings, since 24 April.

Finch Ratings Calculator Screenshot

This effective tariff rate of 20.5% can be used in assessing the impact of import tariffs on US inflation. To evaluate this, I used a method proposed by Scott Bessent during his Senate confirmation hearing. Bessent began by noting that imports account for only 16% of US goods and services that are consumed in the US Economy. In this case, a 10% revenue tariff would increase domestic prices by just 1.6%. With a core inflation rate of 2.8% in the US, this results in a headline inflation rate of 4.4%. Thus, the overall impact of such tariffs on the US economy is relatively modest.

A couple of weeks ago, Austan Goolsbee, the President of the Chicago Fed, noted that tariffs typically increase inflation, which might prompt the Fed to lift rates, but they also reduce economic output, which might prompt the Fed to rate cuts. Consequently, Goolsbee suggested that the Federal Reserve might opt to do nothing. This prediction was successful when the Open Market Committee of the Fed, with Goolsbee as a member, left the Fed Funds rate unchanged last week.

A 90-day agreement between the US and China, masterfully negotiated by Scott Bessent, has dramatically reduced tariffs between China and the US. China now only imposes a 10% import tariff on the US, while the US applies a 30% tariff on Chinese goods—10% as a revenue tariff and 20% to pressure China to curb the supply of fentanyl ingredients to third parties in Mexico or Canada. It is this fentanyl which fuels the US drug crisis. This is a priority for the Trump administration.

How Import Tariffs Affect US Inflation.

We can calculate how much inflation a tariff adds to the US economy in the same way as Scott Bessent by multiplying the effective tariff rate by the proportion that imports are of US GDP. Based on a 20.5% US effective tariff rate, I calculated that it adds 3.28% to the US headline Consumer Price Index (CPI). This results in a US headline inflation rate of 6.1% for the year ahead. In Australia, we can draw parallels to the 10% GST introduced 24 years ago, where price effects were transient and vanished after a year, avoiding sustained high inflation.

Before these negotiations, the US was levying a nominal tariff on China of 145%. Some items were not taxed, so meant that the effective tariff on China was 103%. Levying this tariff meant that the US faced a price effect of 3.28%, contributing to a 6.1% headline inflation rate.

If the nominal tariff rate dropped to 80%, the best-case scenario I considered previously, the price effect would fall to 2.4%, with a headline US inflation rate of 5.2%. With the US now charging China a 30% tariff, this adds only 2% to headline inflation, yielding a manageable 4.8% US inflation rate.

As Goolsbee indicated, the Fed might consider raising interest rates to counter inflation or cutting them to address reduced output, but ultimately, it is likely to maintain current rates, as it did last week. I anticipate the Fed will continue to hold interest rates steady but with an easing bias, potentially cutting rates in the second half of the year once the situation stabilises.

My current Fed Funds rate model suggests that, absent this year's tariff developments, the Fed would have cut rates by 50 basis points. This could be highly positive for the US economy.

Read more
In a lively presentation to the Economic Club of New York, Federal Reserve Bank of Chicago President Austan Goolsbee highlighted tariffs as a minor stagflation risk but emphasized strong U.S. GDP growth of around 2.6%, suggesting a resilient economy and potential for a soft landing.

I’d like to discuss a presentation delivered by Austan Goolsbee, President of the Federal Reserve Bank of Chicago, to the Economic Club of New York on 10 April. Austan Goolsbee, gave a remarkably animated talk about tariffs and their impact on the U.S. economy.

Goolsbee is a current member of the Federal Reserve’s Open Market Committee, alongside representatives from Washington, D.C., and Fed bank Presidents from Chicago, Boston, St. Louis, and Kansas City.  

Having previously served as Chairman of the Council of Economic Advisers in the Obama White House, Goolsbee’s presentation style in New York was notably different from his more reserved demeanour I had previously seen when I had attended a talk of his in Chicago.

During his hour-long, fast-paced talk, Goolsbee addressed the economic implications of tariffs. He recounted an interview where he argued that raising interest rates was not the appropriate response to tariffs, a stance that led some to label him a “Dove.” He humorously dismissed the bird analogy, instead likening himself to a “Data Dog,” tasked with sniffing out the data to guide decision-making.

Goolsbee explained that tariffs typically drive inflation higher, which might ordinarily prompt rate hikes. However, they also tend to reduce economic growth, suggesting a need to cut rates. This creates a dilemma where rates might not need adjustment at all. He described tariffs as a “stagflation event” but emphasised that their impact is minor compared to the severe stagflation of the 1970s.

When asked if the U.S. was heading towards a recession, Goolsbee said that the "hard data" was surprisingly strong.

Let us now look at our model of US GDP based on the Chicago Fed National Activity Index. This Index   incorporates 85 variables across production, sales, employment, and personal consumption.  In the final quarter of last year, this index indicated the GDP growth was slightly below the long-term average, suggesting a US GDP growth rate of 1.9% to 2%.

However, data from the first quarter of this year showed stronger growth, just fractionally below the long-term trend.

Using Our Chicago Fed model, we find that US GDP growth had risen from about 2% growth to a growth rate of around 2.6%, indicating a robust U.S. economy far from recessionary conditions.

Model of US GDP

We think that   increased government revenue from Tariffs might temper domestic demand, potentially guiding growth down towards 1.9% or 2% by year’s end. Despite concerns about tariffs triggering a downturn, this highlights the economy’s resilience and suggests   a “soft landing,” which could allow interest rates to ease, weaken the U.S. dollar, and boost demand for equities.

We will provide monthly reviews of these indicators. We note that, for now, the outlook for the U.S. economy remains very positive.

Read more